col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Future Medicine
  original article Journal Date Title Authors All Authors
1 [GO] Future Virology 2021―Oct―19 Rare cutaneous manifestation of COVID-19 infection and Pfizer-BioNTech COVID-19 vaccine with a unique pattern similarity Anthony Fata, Georges Jabbour, Hampig Kourie, Marianne Zoghbi, Elia Kassouf, Antoine Zoghbi
2 [GO] Personalized Medicine 2021―Oct―15 Personalized therapy: can it tame the COVID-19 monster? Mohd Arish, Farha Naz
3 [GO] Future Virology 2021―Oct―14 Detection of SARS-CoV-2 in the sewerage system in Tunisia: a promising tool to confront COVID-19 pandemic Habib Jmii, Hakima Gharbi-Khelifi, Raouia Assaoudi, Mahjoub Aouni
4 [GO] Nanomedicine 2021―Oct―11 Nano-carriers of COVID-19 vaccines: main pillars of efficacy Carolina Constantin, Anissa Pisani, Giuseppe Bardi, Monica Neagu
5 [GO] Personalized Medicine 2021―Oct―08 Intelligent health system for investigation and consenting COVID-19 patients and precision medicine Zeeshan Ahmed
6 [GO] Future Virology 2021―Oct―08 Computed tomography-positive, SARS-CoV-2 RNA-negative symptomatic contacts of COVID-19 patients: what are their nature and implications? Lei Huang
7 [GO] Future Virology 2021―Oct―08 A case series of pediatric COVID-19 with complicated symptoms in Iran Fatemeh Cheraghali, Leila Barati, Dayan Amanian, Lobat Shahkar, Maryam Najafinejad, Hamed Naziri, et al. (+3)
8 [GO] Future Microbiology 2021―Oct―07 Molecular characterization, phylogenetic and variation analyses of SARS-CoV-2 strains in Turkey Murat Karamese, Didem Ozgur, Emin E Tutuncu
9 [GO] Pain Management 2021―Oct―04 Myofascial pain syndrome and SARS-CoV-2: a case series Jaldhi Patel, Saba Javed
10 [GO] Immunotherapy 2021―Sep―29 Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research Angioletta Lasagna, Marta Muzzana, Paolo Pedrazzoli
11 [GO] Future Virology 2021―Sep―22 Association between blood groups and COVID-19 outcome in Iranian patients Ali Asghar Ayatollahi, Bahman Aghcheli, Abolfazl Amini, Hasan Nikbakht, Parastoo Ghassemzadehpirsala, Emad Behboudi, et al. (+2)
12 [GO] Future Virology 2021―Sep―21 High-value laboratory testing for hospitalized COVID-19 patients: a review Daniela Cihakova, Michael B Streiff, Steven P Menez, Teresa K Chen, Nisha A Gilotra, Erin D Michos, et al. (+8)
13 [GO] Biomarkers in Medicine 2021―Sep―20 Prospective selected biomarkers in COVID-19 diagnosis and treatment Tahani Tabassum, Ahsab Rahman, Yusha Araf, Md A Ullah, Mohammad J Hosen
14 [GO] Future Virology 2021―Sep―10 Fast evolution of SARS-CoV-2 driven by deamination systems in hosts Yanping Zhang, Wen Jiang, Yan Li, Xiaojie Jin, Xiaoping Yang, Pirun Zhang, et al. (+2)
15 [GO] Future Oncology 2021―Sep―03 Predictors of poor precautionary practices towards COVID-19 among cancer patients Abdul R Jazieh, Assia A Bensalem, Adda Bounedjar, Zineb Benbrahim, Mohamed O Alorabi, Atlal M Abusanad, et al. (+9)
16 [GO] Future Cardiology 2021―Sep―03 COVID-19, cardiovascular diseases and cardiac troponins Chan W Kim, Wilbert S Aronow
17 [GO] Future Virology 2021―Sep―02 Serum biochemical parameters as a surrogate marker for chest computed tomography in children with COVID-19 Karuna M Das, Rajvir Singh, Sandeep Subramanya, Shreesh Kumar Ojha, Taleb Almansoori, Dilip Gokhale, Jamal Aldeen Alkoteesh
18 [GO] Biomarkers in Medicine 2021―Sep―02 Emerging treatments for COVID-19: déjà vu all over again? Ricardo AC Lima, Roberto M Ferreira
19 [GO] Future Virology 2021―Sep―02 mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors Emre Yekedüz, Rüveyda Ayasun, Elif Berna Köksoy, Güngör Utkan, Yüksel Ürün, Hakan Akbulut
20 [GO] Future Microbiology 2021―Sep―01 Coronaviruses construct an interconnection way with ERAD and autophagy Aref Movaqar, Atieh Yaghoubi, SA Rahim Rezaee, Saeid A Jamehdar, Saman Soleimanpour
21 [GO] Future Microbiology 2021―Sep―01 SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses Sirio Fiorino, Fabio Tateo, Dario De Biase, Claudio G Gallo, Paolo E Orlandi, Ivan Corazza, et al. (+8)
22 [GO] Journal of Comparative Effectiveness Research 2021―Aug―31 Comparative effectiveness research in COVID-19 using real-world data: methodological considerations Stephanie H Read, Artak Khachatryan, Aastha Chandak, Roman Casciano, Paul Hodgkins, Richard Haubrich, Essy Mozaffari
23 [GO] Immunotherapy 2021―Aug―25 Immune checkpoint inhibitors use and effects on prognosis of COVID-19 infection: a systematic review and meta-analysis Wenwei Qian, Ying Ye, Lugen Zuo, Ting Song, Qing Xu, Yinghong Wang, et al. (+2)
24 [GO] Future Oncology 2021―Aug―25 Thyroid cancer surgery during the coronavirus disease 2019 pandemic: perioperative management and oncological and anatomical considerations Eleftherios Spartalis, Nikolaos Plakopitis, Maria Anna Theodori, Sotirios P Karagiannis, Dimitrios I Athanasiadis, Michael Spartalis, et al. (+4)
25 [GO] Nanomedicine 2021―Aug―25 Carbon nanomaterials as promising substrates in the design of sensors for SARS-CoV-2 and new emerging viral infections Sepideh Abbaszadeh, Ghazal Nikaeen, Saeed Yousefinejad
26 [GO] Biomarkers in Medicine 2021―Aug―18 Usefulness of C-reactive protein/albumin ratio as a predictor of new-onset atrial fibrillation in SARS coronavirus-2 Saban Kelesoglu, Yucel Yilmaz, Eyup Ozkan, Bekir Calapkorur, Zehra B Dursun, Aysegul Ulu-Kilic, Deniz Elcık
27 [GO] Future Virology 2021―Aug―09 Harnessing immunological targets for COVID-19 immunotherapy Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya, Madaswamy S Muthu
28 [GO] Journal of 3D Printing in Medicine 2021―Aug―09 Industrial applications of 3D printing to scale-up production of COVID-19-related medical equipment Muhammad Zaheer Abbas
29 [GO] Future Virology 2021―Jul―29 Independent and incremental prognostic value of D-dimer in hospitalized COVID-19 patients Gerald Chi, Sahar Memar Montazerin, Jane J Lee
30 [GO] Future Microbiology 2021―Jul―28 Relationship of D-dimer and prediction of pulmonary embolism in hospitalized COVID-19 patients: a multicenter study Iftikhar Nadeem, Asad Anwar, Louise Jordon, Noor Mahdi, Masood Ur Rasool, Jonathan Dakin, She Lok
31 [GO] Future Microbiology 2021―Jul―28 Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future? Oloche Owoicho, Kesego Tapela, Alexandra Lindsey Djomkam Zune, Nora Nganyewo Nghochuzie, Abiola Isawumi, Lydia Mosi
32 [GO] Future Oncology 2021―Jul―22 Anxiety levels of breast cancer patients in Turkey during the COVID-19 pandemic Ayse Irem Yasin, Atakan Topcu, Abdallah TM Shbair, Zehra Sucuoglu Isleyen, Ahmet Ozturk, Mehmet Besiroglu, Hacı Mehmet Türk
33 [GO] Biomarkers in Medicine 2021―Jul―21 National Early Warning Score 2 and laboratory predictors correlate with clinical deterioration in hospitalized patients with COVID-19 Gulsah Tuncer, Serkan Surme, Osman F Bayramlar, Hatice K Karanalbant, Betul Copur, Meltem Yazla, et al. (+10)
34 [GO] Neurodegenerative Disease Management 2021―Jul―21 A survey on patients' disease perception and the impact of the COVID-19 pandemic on persons living with amyotrophic lateral sclerosis in Malaysia Suzanna Edgar, Nur Adilah Abdul-Aziz, Ee Chin Loh, David Capelle, Khean-Jin Goh, Lydia Abdul Latif, et al. (+2)
35 [GO] Future Virology 2021―Jul―20 Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation Claudia Cava, Gloria Bertoli, Isabella Castiglioni
36 [GO] Future Virology 2021―Jul―20 An overview of sex hormones in relation to SARS-CoV-2 infection Marzieh Saei Ghare Naz, Mojdeh Banaei, Sareh Dashti, Fahimeh Ramezani Tehrani
37 [GO] Future Virology 2021―Jul―20 In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database Eldar Muhtar, Mengyang Wang, Haimei Zhu
38 [GO] Future Oncology 2021―Jul―19 Uro-oncologic patient management during the COVID-19 pandemic: survey findings from an Italian oncologic hub Stefano Luzzago, Francesco A Mistretta, Enza Dossena, Gianna Comandi, Giovanni Petralia, Dario Di Trapani, et al. (+6)
39 [GO] Future Oncology 2021―Jul―15 Cancer and COVID-19: analysis of patient outcomes Mohamed Aboueshia, Mohammad Hosny Hussein, Abdallah S Attia, Aubrey Swinford, Peter Miller, Mahmoud Omar, et al. (+5)
40 [GO] Journal of 3D Printing in Medicine 2021―Jul―13 Use of 3D printing to support COVID-19 medical supply shortages: a review Stephanie Ishack, Shari R Lipner
41 [GO] Future Virology 2021―Jul―13 Reappraisal of trifluperidol against Nsp3 as a potential therapeutic for novel COVID-19: a molecular docking and dynamics study Ajita Pandey, Mohit Sharma
42 [GO] Future Oncology 2021―Jul―13 Is obesity a risk factor in cancer patients with COVID-19? Robin Park, Elizabeth Wulff-Burchfield, Weijing Sun, Anup Kasi
43 [GO] Future Virology 2021―Jul―13 Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective Shafi Mahmud, Abdo A Elfiky, Al Amin, Sumon Chandro Mohanto, Ekhtiar Rahman, Uzzal Kumar Acharjee, Abu Saleh
44 [GO] Future Virology 2021―Jul―08 Association of anemia and COVID-19 in hospitalized patients Chong Chen, Wenhui Zhou, Wenliang Fan, Xianying Ning, Shuai Yang, Ziqiao Lei, Chuansheng Zheng
45 [GO] Epigenomics 2021―Jul―06 Implication of epitranscriptomics in trained innate immunity and COVID-19 Paramasivam Arumugam, Vijayashree Priyadharsini Jayaseelan
46 [GO] Future Virology 2021―Jul―06 Association of administration of IFN-α with mortality among patients hospitalized with coronavirus disease 2019 Hanqing Liu, Zhouru Ruan, Ziwei Yin, Dan Wu, Hong Zhu
47 [GO] Future Microbiology 2021―Jul―05 Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR Murat Karamese, Didem Ozgur, Ceyda Tarhan, Susamber D Altintas, Okan Caliskan, Aysegul Tuna, et al. (+7)
48 [GO] Future Oncology 2021―Jun―30 Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination Bangyu Luo, Jixi Li, Xianhua Hou, Qiao Yang, Yi Zhou, Jun Ye, et al. (+6)
49 [GO] Future Virology 2021―Jun―30 Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer Roy Chebel, Chris Labaki, Maria Farhat, Joseph Kattan
50 [GO] Future Microbiology 2021―Jun―24 Amuchina Gel Xgerm hand rub in vitro virucidal activity against SARS-CoV-2 Alessandra Capezzone de Joannon, Angela Testa, Natalie Falsetto, Michela Procaccini, Lorella Ragni
51 [GO] Future Virology 2021―Jun―22 The COVID-19 pandemic: an increased risk of rheumatoid arthritis Archana Tripathy, Nitish Swain, Bhawna Gupta
52 [GO] Future Virology 2021―Jun―22 V483A: an emerging mutation hotspot of SARS-CoV-2 Omar Ashwaq, Pratibha Manickavasagam, SK Manirul Haque
53 [GO] Future Virology 2021―Jun―22 Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates Liangyu Peng, Suliman Khan, Ashaq Ali, Saeed Ahmed, Liaqat Ali, Guang Han, Yang Jing
54 [GO] Pharmacogenomics 2021―Jun―18 Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes S Sahana, Ambily Sivadas, Mohit Mangla, Abhinav Jain, Rahul C Bhoyar, Kavita Pandhare, et al. (+47)
55 [GO] Regenerative Medicine 2021―Jun―11 Anticipated impact of stem cell and other cellular medicine clinical trials for COVID-19 Mina Kim, Paul S Knoepfler
56 [GO] Immunotherapy 2021―Jun―11 Appropriate use of antimicrobial therapy for COVID-19 co-infection Chih-Cheng Lai, Wen-Liang Yu
57 [GO] Future Oncology 2021―Jun―09 Telehealth amid the COVID19 pandemic: perception among Asian, Native Hawaiian and Pacific Islander cancer patients Michael Meno, Justin Abe, Jami Fukui, Christa Braun-Inglis, Ian Pagano, Jared Acoba
58 [GO] Future Microbiology 2021―Jun―04 Clinical microbiology laboratories and COVID-19: an interview with Joseph Blondeau Joseph Blondeau
59 [GO] Personalized Medicine 2021―Jun―04 Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection Manik Vohra, Anu Radha Sharma, Kapaettu Satyamoorthy, Padmalatha S Rai
60 [GO] Journal of Comparative Effectiveness Research 2021―Jun―01 Economic burden of lives lost due to COVID-19 in New York State Briana Lui, Michelle Zheng, Robert S White, Marguerite Hoyler
61 [GO] Future Virology 2021―Jun―01 Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery Alireza Mohebbi, Fatemeh Sana Askari, Ali Salehnia Sammak, Mohsen Ebrahimi, Zahra Najafimemar
62 [GO] Nanomedicine 2021―May―28 Special Focus Issue - Applications of nanotechnology against COVID-19: a special focus issue by Nanomedicine Alice Bough
63 [GO] Future Virology 2021―May―24 Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series Ran Cui, Ying Zhu, Yulan Wang, Xiao-Hua Chen, Qiang Li, Sheng-Ming Dai, Qiang Tong
64 [GO] Future Virology 2021―May―19 Natural selection on synonymous mutations in SARS-CoV-2 and the impact on estimating divergence time Yuanyuan Yu, Yan Li, Yu Dong, Xuekun Wang, Chunxiao Li, Wenqing Jiang
65 [GO] Future Virology 2021―May―19 SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses Andrew P Rice, Jason T Kimata
66 [GO] Future Microbiology 2021―May―17 Preventing the next pandemic and tackling antiscience: an interview with Peter Hotez Peter Hotez
67 [GO] Nanomedicine 2021―May―17 Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation Priya Singh, Deepika Singh, Pratikshya Sa, Priyanka Mohapatra, Auromira Khuntia, Sanjeeb K Sahoo
68 [GO] Biomarkers in Medicine 2021―May―14 COVID-19 and diffusing capacity of the lungs for carbon monoxide: a clinical biomarker in postacute care settings Salvatore Fuschillo, Pasquale Ambrosino, Andrea Motta, Mauro Maniscalco
69 [GO] Regenerative Medicine 2021―May―14 Treatment of COVID-19 by stage: any space left for mesenchymal stem cell therapy? Gaia Spinetti, Elisa Avolio, Paolo Madeddu
70 [GO] Biomarkers in Medicine 2021―May―14 Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience Eman Farid, Kannan Sridharan, Ola AM Alsegai, Safa Al Khawaja, Eman J Mansoor, Noor A Teraifi, et al. (+2)
71 [GO] Nanomedicine 2021―May―14 Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics Alaa F Nahhas, Alrayan F Nahhas, Thomas J Webster
72 [GO] Nanomedicine 2021―May―13 Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro Richa Vartak, Suyash M Patil, Aishwarya Saraswat, Manali Patki, Nitesh K Kunda, Ketan Patel
73 [GO] Future Virology 2021―May―12 Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission Emin Gemcioglu, Mehmet Davutoglu, Ramis Catalbas, Berkan Karabuga, Enes Kaptan, Adalet Aypak, et al. (+8)
74 [GO] Journal of 3D Printing in Medicine 2021―May―11 3D printing in surgical simulation: emphasized importance in the COVID-19 pandemic era Ross Michaels, Chelsey A Witsberger, Allison R Powell, Krishna Koka, Katheryn Cohen, Zahra Nourmohammadi, et al. (+2)
75 [GO] Nanomedicine 2021―May―11 How has nanomedical innovation contributed to the COVID-19 vaccine development? João Paulo Figueiró Longo, Luis Alexandre Muehlmann
76 [GO] Future Microbiology 2021―May―11 Metabolite reanalysis revealed potential biomarkers for COVID-19: a potential link with immune response Xin Chen, Mingli Gu, Tengda Li, Yi Sun
77 [GO] Nanomedicine 2021―May―11 Nanotechnology-based self-sterilizing surfaces and their potential in combating coronavirus disease 2019 Parteek Prasher, Mousmee Sharma
78 [GO] Future Microbiology 2021―May―07 Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes Cleo Anastassopoulou, Yiannis Manoussopoulos, Vicky Lampropoulou, Athanasios Tsakris
79 [GO] Journal of 3D Printing in Medicine 2021―May―05 The role of 3D printing in the fight against COVID-19 outbreak Payar Radfar, Sajad Razavi Bazaz, Fateme Mirakhorli, Majid Ebrahimi Warkiani
80 [GO] Immunotherapy 2021―Apr―28 Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i) Marcelo Maia Pinheiro, Andrea Fabbri, Marco Infante
81 [GO] Future Virology 2021―Apr―26 An analysis of inhibition of the severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase by zinc ion: an in silico approach Sina Zoghi, Hossein Jafari Khamirani, Seyed Alireza Dastgheib, Mehdi Dianatpour, Alireza Ghaffarieh
82 [GO] Journal of Comparative Effectiveness Research 2021―Apr―23 Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia Mehmet Agirbasli, Azra Tanrıkulu
83 [GO] Future Virology 2021―Apr―22 HIV and COVID-19 pandemic collision: turning challenges into opportunity Stefano Rusconi, Laura Pezzati, Tiziana Formenti, Andrea Giacomelli
84 [GO] Future Virology 2021―Apr―21 Investigation of the relationship between inherited thrombophilia and novel coronavirus pneumonia Aslihan Kiraz, Seda Guzeldag, Esma Eren, Musa Goksu, Arslan Bayram
85 [GO] Future Cardiology 2021―Apr―20 Characteristics of the 24-hour ambulatory blood pressure monitoring in a COVID-19 survivor Daanyaal Wasim, Bjørn Alme, Stina Jordal, Tomas Mikal Lind Eagan, Marijana Tadic, Giuseppe Mancia, et al. (+2)
86 [GO] Epigenomics 2021―Apr―20 Epigenomics in COVID-19; the link between DNA methylation, histone modifications and SARS-CoV-2 infection Milad Shirvaliloo
87 [GO] Future Virology 2021―Apr―14 The initial infectious dose of SARS-CoV-2 and the severity of the disease: possible impact on the incubation period Hamid Tayebi Khosroshahi, Alireza Mardomi
88 [GO] Future Microbiology 2021―Apr―13 Herd immunity: could it bring the COVID-19 pandemic to an end? Thomas Hugh Pennington
89 [GO] Future Microbiology 2021―Apr―13 The interplay of SARS-CoV-2 and Clostridioides difficile infection Sahil Khanna, Colleen S Kraft
90 [GO] Future Virology 2021―Apr―07 Abnormal myocardial enzymes are important indicators of poor prognosis in COVID-19 patients Jingping Cheng, Wanxin Liu, Siyang Chen, Xiafen Hu, Xiaochen Xiang, Zhongliang Cheng, et al. (+5)
91 [GO] Future Virology 2021―Apr―06 Xerostomia (dry mouth) in patients with COVID-19: a case series Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Fatemeh Atoof, Reza Mottaghi
92 [GO] Biomarkers in Medicine 2021―Mar―29 Serum-soluble ST2 as a novel biomarker reflecting inflammatory status and illness severity in patients with COVID-19 Zhikun Zeng, Xiao-Yue Hong, Yunhui Li, Wei Chen, Guangming Ye, Yirong Li, Yi Luo
93 [GO] Future Virology 2021―Mar―25 Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach Abhigyan Choudhury, Nabarun C Das, Ritwik Patra, Manojit Bhattacharya, Pratik Ghosh, Bidhan C Patra, Suprabhat Mukherjee
94 [GO] Journal of 3D Printing in Medicine 2021―Mar―24 COVID-19 and the worldwide actions to mitigate its effects using 3D printing Guilherme Arthur Longhitano, Jorge Vicente Lopes da Silva
95 [GO] Future Virology 2021―Mar―24 The role of miRNAs in COVID-19 disease Mona Fani, Milad Zandi, Saeedeh Ebrahimi, Saber Soltani, Samaneh Abbasi
96 [GO] Pharmacogenomics 2021―Mar―24 Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in coronavirus disease-2019 patients Mohitosh Biswas
97 [GO] Future Cardiology 2021―Mar―19 SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges Kevin S Shah, Mary Elizabeth Hale Hammond, Stavros G Drakos, Jeffrey L Anderson, James C Fang, Kirk U Knowlton, Robin M Shaw
98 [GO] Future Microbiology 2021―Mar―12 COVID-19 pneumonia: do not leave the corticosteroids behind! Simone Mornese Pinna, Silvia Scabini, Silvia Corcione, Tommaso Lupia, Francesco G De Rosa
99 [GO] Video Journal of Biomedicine 2021―Mar―11 Managing colorectal cancer patients in the COVID-19 era: international discussion on the role of precision medicine in triaging patients
100 [GO] Epigenomics 2021―Mar―09 An immune epigenetic insight to COVID-19 infection Bimal P Jit, Sahar Qazi, Rakesh Arya, Ankit Srivastava, Nimesh Gupta, Ashok Sharma
101 [GO] Future Virology 2021―Mar―09 Erythema multiform-like lesions in a patient infected with SARS-CoV-2: a case report Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Reza Mottaghi
102 [GO] Nanomedicine 2021―Mar―08 Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives Hamid Rashidzadeh, Hossein Danafar, Hossein Rahimi, Faezeh Mozafari, Marziyeh Salehiabar, Mohammad Amin Rahmati, et al. (+13)
103 [GO] Future Virology 2021―Mar―08 Comparative sequence analysis of SARS-CoV-2 suggests its high transmissibility and pathogenicity Kartika Padhan, Mohammad K Parvez, Mohammed S Al-Dosari
104 [GO] Biomarkers in Medicine 2021―Mar―05 Biomarkers to safely discharge head trauma patients in the COVID-19 pandemic era George A Alexiou, Georgios D Lianos, Eleftherios-Spyridon Alexiou, Spyridon Voulgaris
105 [GO] Future Virology 2021―Mar―02 Computational guided approach for drug repurposing against SARS-CoV-2 Jigisha Anand, Tanmay Ghildiyal, Aakanksha Madhwal, Rishabh Bhatt, Devvret Verma, Nishant Rai
106 [GO] Future Oncology 2021―Feb―26 Patient satisfaction with telemedicine for prechemotherapy evaluation during the COVID-19 pandemic Ajithraj Sathiyaraj, Hannah Lopez, Rakesh Surapaneni
107 [GO] Future Virology 2021―Feb―24 Epidemiologic features and clinical course of COVID-19: a retrospective analysis of 19 patients in Germany Sara Elgamasy, Eman Elsayed Sakr, Mohamed Gomaa Kamel, Sherief Ghozy, Ghadeer Gamal Elsayed, Mostafa Mahmoud Fahmy, et al. (+3)
108 [GO] Future Virology 2021―Feb―22 Scouting the receptor-binding domain of SARS coronavirus 2: a comprehensive immunoinformatics inquisition Zaira Rehman, Ammad Fahim, Muhammad Faraz Bhatti
109 [GO] Journal of Comparative Effectiveness Research 2021―Feb―17 Estimates of the value of life lost from COVID-19 in Ohio Peter J Mallow
110 [GO] Future Cardiology 2021―Feb―12 Targeting the SARS-CoV-2 3CLpro and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors Milad Shirvaliloo
111 [GO] Future Microbiology 2021―Feb―11 Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment Laura Kate Gadanec, Tawar Qaradakhi, Kristen R McSweeney, Benazir Ali, Anthony Zulli, Vasso Apostolopoulos
112 [GO] Immunotherapy 2021―Feb―09 Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma Shaukat Ali, Syed M Uddin, Ayesha Ali, Fatima Anjum, Rashid Ali, Elisha Shalim, et al. (+7)
113 [GO] Future Virology 2021―Feb―09 The long-quarantined case of COVID-19 with prolonged viral shedding and intermittent fever for more than 70 days Eijiro Yamada, Emi Ishida, Yasuyo Nakajima, Kazuhiko Horiguchi, Shunichi Matsumoto, Shuichi Okada, et al. (+2)
114 [GO] Future Oncology 2021―Feb―04 The right immune-modulation at the right time: thymosin α1 for prevention of severe COVID-19 in cancer patients Melissa Bersanelli, Diana Giannarelli, Alessandro Leonetti, Sebastiano Buti, Marcello Tiseo, Antonio Nouvenne, et al. (+4)
115 [GO] Future Virology 2021―Feb―04 What is the intermediate host species of SARS-CoV-2? Thomas Friend, Justin Stebbing
116 [GO] Future Oncology 2021―Feb―03 Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit Pietro Quaglino, Paolo Fava, Matteo Brizio, Elena Marra, Marco Rubatto, Martina Merli, et al. (+3)
117 [GO] Future Virology 2021―Feb―03 SARS-CoV-2 direct real-time polymerase chain reaction testing in laboratories with shortage challenges Taghreed Alaifan, Asmaa Altamimi, Dalia Obeid, Turki Alshehri, Shaihana Almatrrouk, Ahmed Albarrag
118 [GO] Journal of 3D Printing in Medicine 2021―Feb―02 3D-printed valves to assist noninvasive ventilation procedures during the COVID-19 pandemic: a case study Guilherme Arthur Longhitano, Geovany Candido, Leonardo Mendes Ribeiro Machado, Paulo Inforçatti Neto, Marcelo Fernandes de Oliveira, Pedro Yoshito Noritomi, et al. (+3)
119 [GO] Future Virology 2021―Jan―28 Asymptomatic carriers of coronavirus disease 2019 among healthcare workers in Isfahan, Iran Hamed Fakhim, Elahe Nasri, Shima Aboutalebian, Sahar Gholipour, Mahnaz Nikaeen, Afsane Vaezi, et al. (+8)
120 [GO] Biomarkers in Medicine 2021―Jan―27 Evaluation of the relation between cardiac biomarkers and thorax computerized tomography findings in COVID-19 patients Cigdem Ileri, Zekeriya Dogan, Beste Ozben, Cagla Karaoglu, Nuran Gunay, Kursat Tigen, et al. (+2)
121 [GO] Future Virology 2021―Jan―26 Severe acute respiratory syndrome coronavirus 2 viral load in respiratory and feces specimens of children with coronavirus disease 2019 Xiang Ma, Liang Su, Lu Cheng, Zhaohua Zhang, Jing Sun, Miao Liu, et al. (+6)
122 [GO] Future Virology 2021―Jan―25 Clinical characteristics of outpatients and inpatients with COVID-19 in Bushehr: a report from the south of Iran Mohsen Keshavarz, Ahmad Tavakoli, Sareh Zanganeh, Mohammad Javad Mousavi, Katayoun Vahdat, Mehdi Mahmudpour, et al. (+3)
123 [GO] Future Microbiology 2021―Jan―25 COVID-19: it is all about sepsis Jean-Louis Vincent
124 [GO] Future Microbiology 2021―Jan―19 Review of the use of nasal and oral antiseptics during a global pandemic Christopher Stathis, Nikolas Victoria, Kristin Loomis, Shaun A Nguyen, Maren Eggers, Edward Septimus, Nasia Safdar
125 [GO] Future Microbiology 2021―Jan―18 The histo-blood group antigens of the host cell may determine the binding of different viruses such as SARS-CoV-2 Mayra Cuéllar-Cruz
126 [GO] Future Virology 2021―Jan―13 Mechanisms of infection by SARS-CoV-2, inflammation and potential links with the microbiome María Magdalena Aguirre García, Javier Mancilla-Galindo, Mercedes Paredes-Paredes, Álvaro Zamudio Tiburcio, Nydia Ávila-Vanzzini
127 [GO] Future Virology 2021―Jan―07 A new perspective of the chemistry and kinetics of inactivation of COVID -19 coronavirus aerosols Michael L Hitchman
128 [GO] Future Microbiology 2021―Jan―06 Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients Reza Ghanbari, Ali Teimoori, Anahita Sadeghi, Ashraf Mohamadkhani, Sama Rezasoltani, Ebrahim Asadi, et al. (+2)
129 [GO] Future Microbiology 2021―Jan―06 Parallels in the pathogenesis of SARS-CoV-2 and M. tuberculosis: a synergistic or antagonistic alliance? Kesego Tapela, Charles Ochieng’ Olwal, Osbourne Quaye
130 [GO] Immunotherapy 2021―Jan―05 An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases Lázaro Manuel Filgueira, Julio Betancourt Cervantes, Orlando Adolfo Lovelle, Carlos Herrera, Carlos Figueredo, Jorge Alain Caballero, et al. (+11)
131 [GO] Future Virology 2020―Dec―24 Relationship between IL-6 and COVID-19: to be considered during treatment Hafize Seda Vatansever, Eda Becer
132 [GO] Future Microbiology 2020―Dec―22 COVID-19: mask efficacy is dependent on both fabric and fit Steven Darby, Krishnakumar Chulliyallipalil, Milosz Przyjalgowski, Paddy McGowan, Simon Jeffers, Alan Giltinan, et al. (+3)
133 [GO] Future Cardiology 2020―Dec―17 A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone induced interstitial pneumonia Luigi Cappannoli, Alessandro Telesca, Roberto Scacciavillani, Edoardo Petrolati, Andrea Smargiassi, Alessia Rabini, et al. (+3)
134 [GO] Future Oncology 2020―Dec―17 TruScreen detection of cervical tissues for high-risk human papillomavirus-infected women during the coronavirus disease 2019 pandemic Ziyao Wang, YaNan Kang, FuRong Yu, Feng-Hui Zhong, Kangni Huang, Xuan Zhou, et al. (+4)
135 [GO] Future Virology 2020―Dec―16 Pandemic response management framework based on efficiency of COVID-19 control and treatment Mustapha D Ibrahim, Fatima AS Binofai, Reem MM Alshamsi
136 [GO] Future Virology 2020―Dec―15 Can natural detergent properties of bile acids be used beneficially in tackling coronavirus disease-19? Yashwant Kumar, Reena Yadav, Alka Bhatia
137 [GO] Immunotherapy 2020―Dec―14 Immunity to glycan α-Gal and possibilities for the control of COVID-19 José de la Fuente, Christian Gortázar, Alejandro Cabezas-Cruz
138 [GO] Journal of 3D Printing in Medicine 2020―Dec―07 COVID-19: additive manufacturing response in the UK Elen J Parry, Craig E Banks
139 [GO] Nanomedicine 2020―Dec―03 New proposal involving nanoformulated melatonin targeted to the mitochondria as a potential COVID-19 treatment Virna Margarita Martín Giménez, Natalia Prado, Emiliano Diez, Walter Manucha, Russel J Reiter
140 [GO] Future Oncology 2020―Dec―02 ‘Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer?’ Retraction notice
141 [GO] Future Oncology 2020―Dec―02 Radiology management of a ‘breast unit’ during COVID-19 pandemic: a single institution experience Christine Salem, Marie-Ange Hajj, Hampig Kourié, Antoine Haddad, Abir Khaddage, Eliane Nasser Ayoub, et al. (+3)
142 [GO] Journal of 3D Printing in Medicine 2020―Dec―01 Pivoting: from academic 3D printing to rapid COVID-19 solutions Allison R Powell, Charles A Keilin, Ross E Michaels, Owen J Tien, Kyle K VanKoevering, Glenn E Green, David A Zopf
143 [GO] Journal of 3D Printing in Medicine 2020―Dec―01 Potential risks of a widespread use of 3D printing for the manufacturing of face masks during the severe acute respiratory syndrome coronavirus 2 pandemic Sven Duda, Sascha Hartig, Karola Hagner, Lisa Meyer, Paula Wessling Intriago, Tobias Meyer, Heinrich Wessling
144 [GO] Future Virology 2020―Nov―30 Phylogenomics and phylodynamics of SARS-CoV-2 genomes retrieved from India Sameera Farah, Ashwin Atkulwar, Manas Ranjan Praharaj, Raja Khan, Ravikumar Gandham, Mumtaz Baig
145 [GO] Future Oncology 2020―Nov―27 COVID-19 and breast cancer: may the microbiome be the issue? Angioletta Lasagna, Valentina Zuccaro, Elisa Ferraris, Marta Corbella, Raffaele Bruno, Paolo Pedrazzoli
146 [GO] Future Oncology 2020―Nov―27 In reply to the Letter to the Editor on: telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities Ronaldo Elkaddoum, Fady Gh Haddad, Roland Eid, Hampig Raphael Kourie
147 [GO] Pharmacogenomics 2020―Nov―27 Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2 mediated SARS-CoV-2 entry Georgia Ragia, Vangelis G Manolopoulos
148 [GO] Journal of Comparative Effectiveness Research 2020―Nov―27 Corticosteroid use in viral pneumonia: experience so far and the dexamethasone breakthrough in coronavirus disease-2019 Mohamed Rafiullah, Khalid Siddiqui
149 [GO] Future Virology 2020―Nov―26 The role of artificial intelligence in tackling COVID-19 Neelima Arora, Amit K Banerjee, Mangamoori L Narasu
150 [GO] Epigenomics 2020―Nov―26 An integrative analysis identifying transcriptional features and key genes involved in COVID-19 Guoping Li, Junyi Wang, Xiang He, Lei Zhang, Qin Ran, Anying Xiong, et al. (+4)
151 [GO] Future Virology 2020―Nov―26 Phylogenetic and whole genome analysis of first seven SARS-CoV-2 isolates in Bangladesh Nadim Sharif, Shuvra K Dey
152 [GO] Future Microbiology 2020―Nov―24 Chloroquine/hydroxycloroquine and COVID-19: need to know more about Antonio Cassone, Licia Iacoviello, Roberto Cauda
153 [GO] Future Microbiology 2020―Nov―20 The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic Lígia N de M Ribeiro, Belchiolina B Fonseca
154 [GO] Future Microbiology 2020―Nov―12 Effective optimization of SARS-CoV-2 laboratory testing variables in an era of supply chain constraints Nikhil S Sahajpal, Ashis K Mondal, Allan Njau, Sudha Ananth, Kimya Jones, Pankaj K Ahluwalia, et al. (+7)
155 [GO] Neurodegenerative Disease Management 2020―Nov―11 Cognitive testing in the COVID-19 era: can existing screeners be adapted for telephone use? Andrew J Larner
156 [GO] Future Microbiology 2020―Nov―06 Clinical microbiology laboratories and COVID-19: the calm before the storm Joseph M Blondeau
157 [GO] Future Microbiology 2020―Nov―06 Risks of SARS-CoV-2 on male reproductive health and the practice of semen analysis and cryopreservation Michael B Yakass, Osbourne Quaye, Bryan J Woodward
158 [GO] Future Virology 2020―Nov―04 LIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic? Su M Metcalfe
159 [GO] Future Microbiology 2020―Nov―03 Coronavirus pandemic: treatment and future prevention Kenneth Lundstrom
160 [GO] Future Cardiology 2020―Oct―30 Cardiology and COVID-19: do we have sufficient information? Nikita Garg, Brendan McClafferty, Devyani Ramgobin, Reshma Golamari, Rahul Jain, Rohit Jain
161 [GO] Future Virology 2020―Oct―28 A multiple-center clinical evaluation of a new real-time reverse transcriptase PCR diagnostic kit for SARS-CoV-2 Jing-Jing Guo, Yan-Hua Yu, Xue-Ying Ma, Ya-Nan Liu, Qian Fang, Pei Qu, et al. (+3)
162 [GO] Future Virology 2020―Oct―27 Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection Rafeed Rahman Turjya, Md. Abdullah-Al-Kamran Khan, Abul Bashar Mir Md. Khademul Islam
163 [GO] Future Virology 2020―Oct―22 Clinical characteristics and outcomes of discharged COVID-19 patients with reoccurrence of SARS-CoV-2 RNA Jing Wu, Xiao-ying Xia, He-lei Liu, Hong Xia, Wen-xiang Huang, Bei Jia, Feng-ying Peng
164 [GO] Future Microbiology 2020―Oct―21 Systemic mycoses: a potential alert for complications in COVID-19 patients Gonzalo Segrelles-Calvo, Glauber R de S Araújo, Susana Frases
165 [GO] Future Microbiology 2020―Oct―21 Mutation profile of over 4500 SARS-CoV-2 isolations reveals prevalent cytosine-to-uridine deamination on viral RNAs Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang
166 [GO] Future Cardiology 2020―Oct―20 Cardiogenic shock following cardiac tamponade and Takotsubo in COVID-19 Asad J Torabi, Josue Villegas-Galaviz, Maya Guglin, Kyle Frick, Roopa Rao
167 [GO] Future Virology 2020―Oct―14 A comprehensive review about SARS-CoV-2 SK Manirul Haque, Omar Ashwaq, Abdulla Sarief, Abdul Kalam Azad John Mohamed
168 [GO] Future Virology 2020―Oct―13 Implications of current and future approaches to coronavirus disease 2019 testing Rasheid Smith, Sean M Geary, Aliasger K Salem
169 [GO] Future Cardiology 2020―Oct―09 Abnormal left ventricular global longitudinal strain by speckle tracking echocardiography in COVID-19 patients Lori B Croft, Parasuram Krishnamoorthy, Richard Ro, Malcolm Anastasius, Wenli Zhao, Samantha Buckley, et al. (+5)
170 [GO] Future Virology 2020―Oct―08 The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19 Jaclyn Kelly Mann, Thumbi Ndung'u
171 [GO] Future Virology 2020―Oct―08 In silico analysis of protein/peptide-based inhalers against SARS-CoV-2 Saad Salman, Fahad Hassan Shah, Maham Chaudhry, Muniba Tariq, Muhammad Yasir Akbar, Muhammad Adnan
172 [GO] Immunotherapy 2020―Sep―22 COVID-19 and the newly rediscovered multidisciplinarity Melissa Bersanelli
173 [GO] Future Microbiology 2020―Sep―21 Potential alteration of COVID-19 by beta-mercaptoethanol Robert E Click
174 [GO] Future Cardiology 2020―Sep―18 Acute type A aortic dissection in a patient with COVID-19 Shiva Tabaghi, Mohammad Ali Akbarzadeh
175 [GO] Pain Management 2020―Sep―18 Reevaluating chronic opioid monitoring during and after the COVID-19 pandemic Prashant N Rao, Rohan Jotwani, Jatin Joshi, Amitabh Gulati, Neel Mehta
176 [GO] Immunotherapy 2020―Sep―16 Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy Melissa Bersanelli, Teresa Zielli, Fabiana Perrone, Chiara Casartelli, Fabiana Pratticò, Elena Rapacchi, et al. (+9)
177 [GO] Immunotherapy 2020―Sep―09 COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy Cesar Martins da Costa, Zenaide Silva de Souza, Alessandra Corte Real Salgues, Guilherme Harada, Pedro Paulo Marino Rodrigues Ayres, Daniela Bulhões Vieira Nunes, et al. (+2)
178 [GO] Future Oncology 2020―Sep―09 Bioethical considerations for cancer patients care during the COVID-19 pandemic Hampig Raphael Kourie, Roland Eid, Fady Gh Haddad, Michel Scheuer, Roland Tomb
179 [GO] Immunotherapy 2020―Sep―09 Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins José María Díez, Carolina Romero, Júlia Vergara-Alert, Melissa Belló-Perez, Jordi Rodon, José Manuel Honrubia, et al. (+4)
180 [GO] Future Microbiology 2020―Sep―03 SARS-CoV-2 transmission, the ambiguous role of children and considerations for the reopening of schools in the fall Cleo Anastassopoulou, Nicholas Spanakis, Athanasios Tsakris
181 [GO] Nanomedicine 2020―Sep―02 No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19 Georgia Wilson Jones, Marco P Monopoli, Luisa Campagnolo, Antonio Pietroiusti, Lang Tran, Bengt Fadeel
182 [GO] Epigenomics 2020―Sep―02 Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5’UTR of SARS-CoV-2 Antonella Baldassarre, Alessandro Paolini, Stefania Paola Bruno, Cristina Felli, Alberto Eugenio Tozzi, Andrea Masotti
183 [GO] Future Oncology 2020―Aug―28 Teleoncology or telemedicine for oncology patients during the COVID-19 pandemic: the new normal for breast cancer survivors? Fatih Yildiz, Berna Oksuzoglu
184 [GO] Future Microbiology 2020―Aug―27 Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19) Elaheh Kordzadeh-Kermani, Hossein Khalili, Iman Karimzadeh
185 [GO] Regenerative Medicine 2020―Aug―26 Digital regenerative medicine and surgery pedagogy for virtual learning in the time of COVID-19 Saranya P Wyles, Fredric B Meyer, Richard Hayden, Isobel Scarisbrick, Andre Terzic
186 [GO] Future Microbiology 2020―Aug―26 Phages in the fight against COVID-19? Andrzej Górski, Ryszard Międzybrodzki, Maciej Żaczek, Jan Borysowski
187 [GO] Future Virology 2020―Aug―26 Investigation of compatibility of severe acute respiratory syndrome coronavirus 2 reverse transcriptase-PCR kits containing different gene targets during coronavirus disease 2019 pandemic Figen Sarıgül, Osman Doluca, Sıla Akhan, Murat Sayan
188 [GO] Future Virology 2020―Aug―26 Genetic and pathogenic characterization of SARS-CoV-2: a review Afsane Bahrami, Gordon A Ferns
189 [GO] Future Oncology 2020―Aug―20 Breast cancer surgery after the COVID-19 pandemic Fiona Tsang-Wright, Marios-Konstantinos Tasoulis, Nicola Roche, Fiona MacNeill
190 [GO] Future Virology 2020―Aug―18 A flow virometry process proposed for detection of SARS-CoV-2 and large-scale screening of COVID-19 cases Niraja Soni, Puja Pai, Gurumurthy Raja Krishna Kumar, Venkatesh Prasad, Santanu Dasgupta, Bhaskar Bhadra
191 [GO] Future Virology 2020―Aug―17 Susceptibility of the Iranian population to severe acute respiratory syndrome coronavirus 2 infection based on variants of angiotensin I converting enzyme 2 Alireza Mohebbi, Fatemeh Sana Askari, Mohsen Ebrahimi, Mana Zakeri, Mohammad Yasaghi, Hanieh Bagheri, Naeme Javid
192 [GO] Future Microbiology 2020―Aug―14 Anal swab as the potentially optimal specimen for SARS-CoV-2 detection to evaluate the hospital discharge of COVID-19 patients Mei Sun, Dong Guo, Jing Zhang, Jian Zhang, Hai-Feng Teng, Jun Xia, et al. (+3)
193 [GO] Future Virology 2020―Aug―12 Thoughts on detecting tissue distribution of potential COVID-19 receptors Hongtao Tang, Xiaosheng Lu, Shuyan Qie, Jianing Xi
194 [GO] Pain Management 2020―Aug―10 Impact of COVID-19 on chronic pain patients: a pain physician’s perspective Saba Javed, Joey Hung, Billy K Huh
195 [GO] Future Oncology 2020―Aug―10 Recapitulating intracavitary brachytherapy in cervical cancer patients during the COVID-19 pandemic: a viewpoint Divyesh Kumar, Treshita Dey
196 [GO] Colorectal Cancer 2020―Aug―07 Therapeutic challenges in colorectal surgery practice during COVID-19 outbreak: a case series Mahdi Alemrajabi, Mohammad Moradi, Esmail Amiri, Masoud Vahdani
197 [GO] Future Cardiology 2020―Aug―04 Biventricular strain by speckle tracking echocardiography in COVID-19: findings and possible prognostic implications Parasuram Krishnamoorthy, Lori B Croft, Richard Ro, Malcolm Anastasius, Wenli Zhao, Gennaro Giustino, et al. (+5)
198 [GO] Melanoma Management 2020―Jul―31 Pandemic medicine: the management of advanced melanoma during COVID-19 James R Patrinely, Douglas B Johnson
199 [GO] Nanomedicine 2020―Jul―29 Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19 Noura H Abd Ellah, Sheryhan F Gad, Khalid Muhammad, Gaber E Batiha, Helal F Hetta
200 [GO] Future Virology 2020―Jul―29 In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome Bader Y Alhatlani
201 [GO] Future Virology 2020―Jul―27 COVID-19: studying the global pandemic - foreword Stefano Rusconi, Frederick G Hayden
202 [GO] Future Virology 2020―Jul―27 Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future Mubasher Rehman, Isfahan Tauseef, Bibi Aalia, Sajid Hussain Shah, Muhammad Junaid, Kashif Syed Haleem
203 [GO] Future Oncology 2020―Jul―27 Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic Hagar Elghazawy, Joaira Bakkach, Mohamed S Zaghloul, Atlal Abusanad, Mariam Mohamed Hussein, Mohamed Alorabi, et al. (+6)
204 [GO] Biomarkers in Medicine 2020―Jul―21 The role of hematological parameters in COVID-19 patients in the emergency room Eren Usul, İshak Şan, Burak Bekgöz, Ali Şahin
205 [GO] Immunotherapy 2020―Jul―17 Obesity, COVID-19 and immunotherapy: the complex relationship! Carmine Finelli
206 [GO] Future Oncology 2020―Jul―17 How does COVID-19 fear and anxiety affect chemotherapy adherence in patients with cancer Cengiz Karacin, Irem Bilgetekin, Fatma B Basal, Omur B Oksuzoglu
207 [GO] Future Microbiology 2020―Jul―17 COVID-19: in the absence of vaccination - ‘mask-the-nation’ Roy D Sleator, Steven Darby, Alan Giltinan, Niall Smith
208 [GO] Biomarkers in Medicine 2020―Jul―17 The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort Shant Ayanian, Juan Reyes, Lei Lynn, Karolyn Teufel
209 [GO] Immunotherapy 2020―Jul―15 Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients Juan David Cala-García, Juan David Sierra-Bretón, Jorge Eduardo Cavelier-Baiz, Álvaro A Faccini-Martínez, Carlos Eduardo Pérez-Díaz
210 [GO] Future Microbiology 2020―Jul―14 N-acetylcysteine as a potential treatment for novel coronavirus disease 2019 Rangel-Méndez Jorge-Aarón, Moo-Puc Rosa-Ester
211 [GO] Future Oncology 2020―Jul―13 The psychological challenges for oncological patients in times of COVID-19 pandemic: telemedicine, a solution? Estelle Caroline Schade, Ronaldo Elkaddoum, Hampig Raphael Kourie
212 [GO] Future Oncology 2020―Jul―13 The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer Veronica Mollica, Alessandro Rizzo, Francesco Massari
213 [GO] Future Cardiology 2020―Jul―10 The impact of COVID-19 on critical cardiac care and what is to come postpandemic Justin Hall
214 [GO] Immunotherapy 2020―Jul―09 How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology Ting Yi Jessica Chang, Janet E Pope
215 [GO] Future Microbiology 2020―Jul―08 The use of radiological imaging alongside reverse transcriptase PCR in diagnosing novel coronavirus disease 2019: a narrative review Michael Naguib, Fathi Moustafa, Mustafa Thaer Salman, Nermin Kamal Saeed, Manaf Al-Qahtani
216 [GO] Future Cardiology 2020―Jul―03 Sudden cardiac death in COVID-19 patients, a report of three cases Samira Shirazi, Sanaz Mami, Negar Mohtadi, Abas Ghaysouri, Hamed Tavan, Ali Nazari, et al. (+2)
217 [GO] Future Cardiology 2020―Jul―01 Coronavirus disease 2019 is delaying the diagnosis and management of chest pain, acute coronary syndromes, myocarditis and heart failure Bhurint Siripanthong, Thomas C Hanff, Michael G Levin, Mahesh K Vidula, Mohammed Y Khanji, Saman Nazarian, Choudhary Anwar A Chahal
218 [GO] Immunotherapy 2020―Jun―29 Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19 Lidia Gatto, Enrico Franceschi, Vincenzo Di Nunno, Alba Ariela Brandes
219 [GO] Future Oncology 2020―Jun―27 Implications of COVID-19 on urological laparoscopic surgery Benjamin Condon, Thomas Whish-Wilson, Niall F Davis, Nathan Lawrentschuk
220 [GO] Future Virology 2020―Jun―26 COVID-19 in homeless populations: unique challenges and opportunities Brian Conway, David Truong, Kelli Wuerth
221 [GO] Future Oncology 2020―Jun―25 Cancer management challenge in a developing country in COVID-19 pandemic: reflection of a group of Moroccan oncologists Hind Mrabti, Narjiss Berrada, Ghislaine Raiss, Hamza Ettahri, Halima Abahssain, Mouna Bourhafour, et al. (+2)
222 [GO] Future Oncology 2020―Jun―22 A clinical dilemma amid COVID-19 pandemic: missed or encountered diagnosis of cancer? Emre Yekedüz, Ayşe Müge Karcıoğlu, Güngör Utkan, Yüksel Ürün
223 [GO] Colorectal Cancer 2020―Jun―20 Official French SARS-CoV-2 guidelines for cancer patients, a triage solution with precision medicine Juan Manuel O’Connor, Federico Esteso, Matías Chacón
224 [GO] Immunotherapy 2020―Jun―17 Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019 Megan Melody, Jared Nelson, Jacquelyn Hastings, Joshua Propst, Michael Smerina, Julio Mendez, Pramod Guru
225 [GO] Future Virology 2020―Jun―12 COVID-19 and coronaviral hepatitis: evidence of collateral damage Mohammad K Parvez
226 [GO] Future Virology 2020―Jun―12 Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection Jie Tan, Shousheng Liu, Likun Zhuang, Lizhen Chen, Mengzhen Dong, Jie Zhang, Yongning Xin
227 [GO] Future Microbiology 2020―Jun―11 Focus on a 2019-novel coronavirus (SARS-CoV-2) Ling-Pu Zhang, Meixian Wang, Yanping Wang, Jun Zhu, Nannan Zhang
228 [GO] Pharmacogenomics 2020―Jun―10 Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing? Elissar Moujaess, Hampig Raphael Kourie, Joseph Kattan
229 [GO] Pharmacogenomics 2020―Jun―05 Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations Eric M Snyder, Bruce D Johnson
230 [GO] Epigenomics 2020―Jun―04 Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents Sameer Ayaz, Francesco Crea
231 [GO] Biomarkers in Medicine 2020―Jun―03 Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19 Juyi Li, Meng Li, Shasha Zheng, Menglan Li, Minghua Zhang, Minxian Sun, et al. (+4)
232 [GO] Immunotherapy 2020―Jun―03 Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors Patrizia Vici, Laura Pizzuti, Eriseld Krasniqi, Andrea Botticelli, Gennaro Ciliberto, Maddalena Barba
233 [GO] Future Oncology 2020―May―29 The future of cancer research after COVID-19 pandemic: recession? Hampig Raphael Kourie, Roland Eid, Fady Haddad, Marwan Ghosn, Dolla Karam Sarkis
234 [GO] Future Virology 2020―May―29 A suspected case of COVID-19 turned into a confirmed case: a case report from Iran Di Yang, Kai Wei, Xuesong Gao, Yijin Zhang, Ping Gao, Hongjie Li, et al. (+5)
235 [GO] Future Oncology 2020―May―29 Facing SARS-CoV-2 outbreak in immunotherapy era Fabrizio Citarella, Marco Russano, Francesco Pantano, Emanuela Dell'Aquila, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
236 [GO] Nanomedicine 2020―May―28 Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic? Vuk Uskoković
237 [GO] Future Oncology 2020―May―27 Hematopoietic stem cell transplantation dilemma during the COVID-19 era Ramy Samaha, Joseph Kattan
238 [GO] Future Oncology 2020―May―27 Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer? Priya Hays
239 [GO] Future Oncology 2020―May―26 Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era Antonello Veccia, Stefania Kinspergher, Mariachiara Dipasquale, Orazio Caffo
240 [GO] Future Virology 2020―May―26 Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise John Nemunaitis, Laura Stanbery, Neil Senzer
241 [GO] Future Oncology 2020―May―21 Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy Alba A Brandes, Andrea Ardizzoni, Fabrizio Artioli, Federico Cappuzzo, Luigi Cavanna, Giovanni Luca Frassineti, et al. (+8)
242 [GO] Future Virology 2020―May―20 Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections Mona Fani, Ali Teimoori, Shokouh Ghafari
243 [GO] Biomarkers in Medicine 2020―May―19 Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis Nicola Ielapi, Noemi Licastro, Michele Provenzano, Michele Andreucci, Stefano de Franciscis, Raffaele Serra
244 [GO] Future Oncology 2020―May―15 The management of patients with metastatic prostate cancer during the COVID-19 pandemic Tarek Assi, Nathalie Ibrahim, Rita-Maria K Abboud, Clarisse Kattan, Elie Rassy, Elie Nemr, Joseph Kattan
245 [GO] Future Oncology 2020―May―14 Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19 Xuan Rui Sean Ong, Benjamin Condon, Dominic Bagguley, Nathan Lawrentschuk, Arun Azad, Declan Murphy
246 [GO] Future Oncology 2020―May―14 Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what’s old is new again? Ellen O'Connor, Jiasian Teh, Ashish M Kamat, Nathan Lawrentschuk
247 [GO] Future Oncology 2020―May―14 Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients’ care Francesco Massari, Veronica Mollica, Stefania Salvagni, Michele Tognetto, Andrea Ardizzoni
248 [GO] Future Oncology 2020―May―14 Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy) Elisa Maria Stroppa, Ilaria Toscani, Chiara Citterio, Elisa Anselmi, Elena Zaffignani, Mauro Codeluppi, Luigi Cavanna
249 [GO] Immunotherapy 2020―May―13 Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens José-María Díez, Carolina Romero, Rodrigo Gajardo
250 [GO] Future Virology 2020―May―12 Prediction and analysis of key protein structures of 2019-nCoV Qihao Li, Wen Peng, Yu Ou
251 [GO] Journal of Comparative Effectiveness Research 2020―May―11 Life after COVID-19: R WE going to help? Sreeram V Ramagopalan, Radek Wasiak
252 [GO] Nanomedicine 2020―May―07 Application of nanomaterials in treatment, anti-infection and detection of coronaviruses Ghazal Nikaeen, Sepideh Abbaszadeh, Saeed Yousefinejad
253 [GO] Future Oncology 2020―May―01 Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities Ronaldo Elkaddoum, Fady Gh Haddad, Roland Eid, Hampig Raphael Kourie
254 [GO] Lung Cancer Management 2020―May―01 Lung cancer management challenges amidst COVID-19 pandemic: hope lives here Abhishek Shankar, Deepak Saini, Ruchir Bhandari, Sachidanand Jee Bharati, Sunil Kumar, Geetika Yadav, et al. (+2)
255 [GO] Immunotherapy 2020―Apr―30 COVID-19: the use of immunotherapy in metastatic lung cancer Alexander P Davis, Michael Boyer, Jenny H Lee, Steven C Kao
256 [GO] Future Virology 2020―Apr―24 The divergence between SARS-CoV-2 and RaTG13 might be overestimated due to the extensive RNA modification Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang
257 [GO] Future Oncology 2020―Apr―23 What the oncologist needs to know about COVID-19 infection in cancer patients Elie Rassy, Rita-Maria Khoury-Abboud, Nathalie Ibrahim, Clarisse Kattan, Tarek Assi, Joseph Kattan
258 [GO] Future Oncology 2020―Apr―23 The impact of the coronavirus pandemic on the management of cancer patients in Lebanon: a single institutional experience Clarisse Kattan, Hassan Badreddine, Elie Rassy, Hampig Raphael Kourie, Joseph Kattan
259 [GO] Future Cardiology 2020―Apr―17 Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic Nili Schamroth Pravda, Miri Schamroth Pravda, Ran Kornowski, Katia Orvin
260 [GO] Future Virology 2020―Apr―17 Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2 Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang
261 [GO] Colorectal Cancer 2020―Apr―16 Colorectal cancer care in the age of coronavirus: strategies to reduce risk and maintain benefit John L Marshall, Ronit I Yarden, Benjamin A Weinberg
262 [GO] Immunotherapy 2020―Apr―15 Do checkpoint inhibitors compromise the cancer patients’ immunity and increase the vulnerability to COVID-19 infection? Joseph Kattan, Clarisse Kattan, Tarek Assi
263 [GO] Future Oncology 2020―Apr―08 The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic Nizar Bitar, Joseph Kattan, Hampig Raphael Kourie, Deborah Mukherji, Nagi El Saghir
264 [GO] Immunotherapy 2020―Mar―26 Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors Melissa Bersanelli


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.051 sec